Humans: Nabeel ALI, et al. Département de médecine du travail et d'hygiène du milieu, Faculté de médecine, Université de Montréal-We studied the toxicokinetic fate of toluene (TOL) and n-hexane (HEX) in rats exposed to mixtures of these solvents by inhalation during 4 hours. We developed and validated a physiologically based toxicokinetic (PBTK) model for this binary mixture in the rat, which after proper scaling, was used to predict the impact of combined exposure to TOL and HEX in humans. Simultaneous exposure to TOL (125-300 ppm) did not affect the kinetics of HEX (100 or 800 ppm) in blood in rats. Coexposure to HEX, however, increased the concentration of TOL in blood. Coexposure strongly reduced the urinary excretion of 2,5-hexanedione (HD) (up to 75% reduction for TOL 300 ppm + HEX 100 ppm) whereas the urinary excretion of HA and o-CR were reduced to a lesser extent (up to 28% reduction for TOL 200 ppm + HEX 100 ppm). Simulations of exposure to various TOL-HEX mixtures with the human PBTK model suggested that at concentration corresponding to their respective exposure limit values (TOL: 50 ppm; HEX: 50 ppm) coexposure during 7 hours would result in only slight effects on their respective kinetics. This study showed 1) that exposure indicators such as the blood concentration of unchanged TOL and HEX or the amount of their respective urinary metabolite(s) are not equally sensitive to the occurrence of a metabolic interaction and, 2) that such difference of sensitivity can be predicted a priori using a PBTK modeling approach. (J Occup Health 1999; 41: 95-103) Key words: Toluene, n-Hexane, Coexposure, Toxicokinetic Modeling, Biological monitoring,
Toluene (TOL) and n-hexane (HEX) are used together in several industrial applications (e.g., adhesive compounds, and paints) and therefore workers are likely to be exposed simultaneously to these two solvents.
Both have neurotoxic properties. While TOL has been shown to exert its main toxic effect through perturbation of the central nervous system 1) , HEX rather affects the peripheral nervous system through the production of a toxic metabolite, namely 2,5-hexanedione (HD) 2) . Each is known to be mainly metabolized by different forms of cytochrome P-450, including CYP 2E1 and CYP 2B6 [3] [4] [5] [6] [7] [8] . Perbellini et al. 9) reported that a mutual noncompetitive interference existed between TOL and HEX under in vitro conditions. In addition, it was shown that coexposure to TOL decreased the toxic effect of HEX on the peripheral nerve, an effect that has been ascribed to the decrease in the production of HD 10) . The objectives of the present study were 1) to investigate the toxicokinetic fate of TOL and HEX in rats exposed to mixtures of these solvents by inhalation and, 2) to verify whether such potential impact could be described/predicted using a physiologically based toxicokinetic (PBTK) modeling approach.
Materials and methods

Animals
Adult Sprague-Dawley male rats (Charles River Canada, St-Constant, Québec) weighing approximately 250-280 g were used in this study. Prior to use and during experiments, the animals were housed in a humidity-and temperature-controlled room with a 12-h light/dark cycle. The animals were not provided with food and water during inhalation exposures.
Chemicals
HEX (99%), TOL (99.8%) and HD (98%) were obtained from Aldrich Chemicals (Milwaukee, Wisc.) and were used as supplied.
Inhalation exposures
Groups of 5 or 6 rats were exposed during 4 h (9.00 A.M.-13.00 P.M.) to TOL or HEX alone, or to several mixtures containing both solvents (Table 1) . Exposures took place in a dynamic exposure chamber of 500-l (Unifab, Kalamazoo, Mich.) for which the airflow was set at approximately 300 l/min. Solvents were delivered with a high-pressure liquid chromatography (HPLC) pump (Varian Canada, Montréal) into the inlet ducting of the chamber where they were mixed with clean compressed air. Solvent concentration was monitored by injecting 1.0 ml of the chamber atmosphere into a gas chromatograph as previously described 11) .
Determination on unchanged solvents in blood
The concentration of TOL and HEX in blood was measured at various time points (5, 30, 60, 90, 120 and 150 min) following the end of exposure. Determinations were made by head-space analysis using a Tekmar ® headspace sampler and a Hewlett-Packard 5890A gas chromatograph equipped with a flame ionization detector according to a procedure described elsewhere 11) . The blood analysis was conducted immediately after the blood sampling.
Determination of urinary metabolites
Urine was collected during a period of 24 h beginning at the onset of inhalation exposure. Non-conjugated and total HD were measured by gas-chromatography 12) . The content of hippuric acid (HA) was measured by HPLC according to the method proposed by Poggi et al. 13) The concentration of o-cresol (o-CR) was determined by gas chromatography with flame ionization detection according to a method developed by Truchon et al. 14) PBTK modeling of single and combined exposures in rats A PBTK model was constructed for each solvent individually. Each PBTK model consisted of four compartments as described by Ramsey and Andersen (1984) 15) : liver, fat, slowly perfused tissues, richly perfused tissues (Fig. 1) . The individual models were d e v e l o p e d b y o b t a i n i n g t h e p h y s i o l o g i c a l , physicochemical and biochemical parameters in the literature (Table 2) . Metabolism was limited to the liver compartment and described as a saturable process. Metabolic constants of HEX (Vmax: 1.35 mg/kg/hr; Km: 0.4 mg/l) were obtained by optimization and correspond to the values that best describe the blood concentrationtime course curves for HEX obtained following exposure of rats to 100, 200 and 800 ppm of HEX (Fig. 2 ). The PBTK model for the binary mixture of TOL and HEX consisted of two individual models linked via the metabolism term ( Fig. 1) which was modified to test various mechanisms of metabolic interaction. This was achieved by modifying the basic saturable hepatic metabolism term to accommodate three types of metabolic inhibition mechanisms, namely, competitive, non-competitive and uncompetitive 16) . Urinary excretion of HD in the rat was modeled by incorporating the excretion constants used by Yu et al. 22) to describe such excretion in humans, except that the percentage of HEX metabolized converted to hexanols in rats had to be set at 21%. Urinay excretion of o-CR was described assuming that 0.7% of toluene metabolized is converted to o-CR and that o-CR half-line in urine is 3.5 h 28) .
PBTK modeling of TOL-HEX interaction in humans
The structure of the PBTK model used to describe the kinetics of TOL and HEX in humans was identical to the one developed for the rat. The numerical values of the species-specific model parameters, however, were replaced with those for humans. The approach involved (i) substituting rat physiological parameters and blood: air partition coefficients with those for human, (ii) scaling the Vmax on the basis of body weight 0.75 , and (iii) keeping all other models parameters species-invariant. The human and rat PBTK model for TOL have been used in previous studies 16, 17) . The human PBTK model for HEX allowed a good description of the concentration of unchanged HEX measured in venous blood of volunteers exposed to 100 and 200 ppm of HEX during 4 h (data not shown) 18) . In addition, the model successfully predicted the alveolar concentration of HEX (experimental: ~ 41 ppm; predicted: 43 ppm) in volunteers exposed to 60 ppm of HEX during 15.5 min 19) . The rat and human interaction PBTK models were used to simulate the impact of simultaneous exposure to TOL and HEX on their respective kinetics in both species.
Model simulation
The algebraic and differential equations describing the toxicokinetics of TOL and HEX were written as a program and solved with a commercially available software, namely ACSL (Advanced Continuous Simulation Language; Mitchell and Gauthier Associates, Huntsville, AL). Optimizations were performed using ACSL Optimize v.2.1. Program (Mitchell and Gauthier Associates, Huntsville, AL).
Statistics
Differences between various treatments on the blood concentration of TOL and HEX and on the amount of metabolites excreted in urine were tested using one-way ANOVA or Student-t-test. The level of significance was set at 0.05. Figure 2 depicts the venous blood concentration of unchanged HEX obtained in rats exposed during 4 h to either 100, 200 or 800 ppm of HEX. It shows that the PBTK model for the rat allows a good description of the blood kinetics of HEX under these exposure conditions. The best fit of experimental data was achieved when the values of Vmax and Km were set at 1.35 mg/kg/hr and 0.4 mg/l, respectively.
Results
Single exposure to HEX
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Simultaneous exposure to TOL does not affect the kinetics of unchanged HEX in blood of rats exposed to 100 or 800 ppm of HEX (Fig 3A, B) . Conversely, the 25) . e This study. f Sato (1991) 27) .
Fig. 2. Comparison of PBTK model simulations (lines) of venous blood
concentrations of HEX with experimental data (symbols) obtained in rats exposed for 4 h to 3 concentrations of HEX. Each data point represents the mean (± SD) of 5 rats. concentration of TOL in blood of rats exposed to 100 or 200 ppm of TOL is increased by co-exposure to (100 or 800 ppm) HEX. These results are in accordance with the PBTK model predictions (Fig. 4A, B) . Excretion of urinary metabolites Coexposure to TOL strongly reduces the urinary excretion of HD (Fig. 5) . The reduction of unconjugated (free) HD is 60%, 66% and 74% when exposure concentration of TOL is 125, 200 or 300 ppm, respectively. For total HD, the corresponding values are 54%, 74% and 78%. On the other hand, as depicted in Figure 6 , the urinary excretion of HA and o-CR is also reduced but to a lesser extent (10% to 28%) (not statistically significant) as a result of coexposure. The extent of reduction of the amount of HEX and TOL metabolized provided by the PBTK model for the binary mixture is close to what was observed experimentally in rats (Table 3) .
Discussion
The present study indicates that combined inhalation exposure to TOL and HEX resulted in toxicokinetic interference probably as a result of mutual metabolic interaction between them. Perbellini et al. 9) have reported that simultaneous oral administration of TOL and HEX resulted in metabolic interference; combined exposure decreased the urinary excretion of HEX metabolites whereas that of TOL was not modified. These authors suggested that the ability to TOL to interfere with HEX metabolism might explain the observations made by Takeuchi et al. 10) who reported that rats treated with HEX-TOL mixture showed slighter neurotoxic effect compared to rats which received HEX only. Likewise, Iwata et al. 12) also reported that inhalation coexposure to high concentrations TOL (1,000 ppm) and HEX (1,000 ppm) during 8h caused an important reduction of the production of HEX metabolites, including HD. More recently, Baelum et al. 20) reported the results of a human study suggesting that metabolic interactions are likely to occur between TOL, HEX and trichloroethylene at concentrations corresponding to their inhalation exposure limits. PBTK modeling provided a good description of the blood kinetics of both solvents in rats exposed to various mixtures. Such a good fit was achieved whatever the mechanism of inhibition tested (i.e., competitive, noncompetitive, uncompetitive) simply by adjusting by optimization the value of the inhibition constants (Table  4) . Based on these values, non-competitive or uncompetitive inhibition appeared to be a plausible mechanism of interaction.
This study shows that exposure indicators such as the blood concentration of unchanged solvent or the amount of a urinary metabolite are not equally sensitive to the occurrence of a metabolic interaction. Indeed, exposure to mixtures increased the blood concentration of TOL and did not affect significantly the production of TOL metabolites. On the other hand, although the blood concentration of HEX remained unchanged, exposures to mixtures caused a dramatic reduction of the urinary excretion of HD. Such difference in indicator sensitivity has recently been reported for another mixture containing m-xylene and methylchloroform 21) . The human PBTK model was used to simulate exposure to various TOL-HEX mixtures. Figures 7 show that at concentrations corresponding to their respective exposure limit values (TOL: 50 ppm; HEX: 50 ppm) coexposure during 7 h results in only slight effects on their respective kinetics. Figure 8 shows that human exposure to mixtures of TOL and HEX, at concentrations corresponding to those tested in the present study with rats, would result in significant reduction of urinary excretion of TOL and HEX metabolites. However, at their respective exposure limit such reduction would be considerably less. In this regard, recently Yu et al. 22) , using a PBTK modeling approach, showed that human exposure to mixtures of TOL and HEX, at concentrations corresponding to their respective exposure limits, could affect the urinary excretion of HD, in a dose-dependant fashion. The slight reduction predicted in their study is in accordance with the observation made in the present study showing that urinary HD is more sensitive to TOL exposure than unchanged HEX in blood. 
